Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in PROK — Prokidney Corp.

CIK 1390777 NEW YORK, NY
Back to PROK Full portfolio

Position in PROK

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$360,379
+$340,347 QoQ
Shares Held
176,657
+1478.4% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 70 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in PROK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. PROK ranks #267 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in PROK

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $360,379 176,657
2026-03-31 $20,032 11,192
2025-12-31 $25,069 11,192
2025-09-30 $27,084 11,192